MMFS-202-302

· Northwestern University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MMFS-202-302, covering 2025-06-22 to 2025-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia [Phase 2]